John Simmons

Company: Natera

Job title: Global Vice President - Biopharma

Seminars:

Advancing Our Understanding of ctDNA Dynamics to Guide Drug Development 10:15 am

Review published and presented data supporting the role of ctDNA in early relapse detection and therapy response prediction. Highlight insights gained from >150 MRD studies involving more >50 biopharma collaborators, encompassing a wide range of therapeutic modalities and tumor types Discuss how Natera’s extensive real-world database, encompassing >230,000 patients and >800,000 ctDNA timepoints, can be…Read more

day: Day Two